Literature DB >> 31528702

TP53INP2 at the crossroad of apoptosis and autophagy in death receptor signaling.

Saška Ivanova1,2,3, Antonio Zorzano1,2,3.   

Abstract

The binding of ligands to death receptors elicits distinct outcomes, such as apoptosis, inflammation and necroptosis, depending on the cellular context. We have recently described that the autophagic protein TP53INP2 favors apoptosis upon death receptor signaling and is a potential biomarker of responsiveness to TRAIL treatment.

Entities:  

Keywords:  TP53INP2; TRAIL; apoptosis; autophagy; death receptor signaling

Year:  2019        PMID： 31528702      PMCID： PMC6736201          DOI： 10.1080/23723556.2019.1632687

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN： 2372-3556


  10 in total

1.  Regulation of death receptor signaling by the autophagy protein TP53INP2.

Authors:  Saška Ivanova; Mira Polajnar; Alvaro Jesus Narbona-Perez; Maria Isabel Hernandez-Alvarez; Petra Frager; Konstantin Slobodnyuk; Natalia Plana; Angel R Nebreda; Manuel Palacin; Roger R Gomis; Christian Behrends; Antonio Zorzano
Journal:  EMBO J       Date:  2019-04-12       Impact factor: 11.598

2.  TP53INP2 contributes to autophagosome formation by promoting LC3-ATG7 interaction.

Authors:  Zhiyuan You; Yinfeng Xu; Wei Wan; Li Zhou; Jin Li; Tianhua Zhou; Yin Shi; Wei Liu
Journal:  Autophagy       Date:  2019-02-20       Impact factor: 16.016

3.  FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

Authors:  J P Medema; C Scaffidi; F C Kischkel; A Shevchenko; M Mann; P H Krammer; M E Peter
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

4.  Autophagy as a mechanism of Apo2L/TRAIL resistance.

Authors:  Arishya Sharma; Alexandru Almasan
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

5.  Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis.

Authors:  Silvia von Karstedt; Annalisa Conti; Max Nobis; Antonella Montinaro; Torsten Hartwig; Johannes Lemke; Karen Legler; Franka Annewanter; Andrew D Campbell; Lucia Taraborrelli; Anne Grosse-Wilde; Johannes F Coy; Mona A El-Bahrawy; Frank Bergmann; Ronald Koschny; Jens Werner; Tom M Ganten; Thomas Schweiger; Konrad Hoetzenecker; Istvan Kenessey; Balazs Hegedüs; Michael Bergmann; Charlotte Hauser; Jan-Hendrik Egberts; Thomas Becker; Christoph Röcken; Holger Kalthoff; Anna Trauzold; Kurt I Anderson; Owen J Sansom; Henning Walczak
Journal:  Cancer Cell       Date:  2015-04-02       Impact factor: 31.743

6.  The nuclear cofactor DOR regulates autophagy in mammalian and Drosophila cells.

Authors:  Caroline Mauvezin; Meritxell Orpinell; Víctor A Francis; Francisco Mansilla; Jordi Duran; Vicent Ribas; Manuel Palacín; Patricia Boya; Aurelio A Teleman; Antonio Zorzano
Journal:  EMBO Rep       Date:  2009-12-04       Impact factor: 8.807

7.  Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling.

Authors:  Zhaoyu Jin; Yun Li; Robert Pitti; David Lawrence; Victoria C Pham; Jennie R Lill; Avi Ashkenazi
Journal:  Cell       Date:  2009-05-07       Impact factor: 41.582

8.  Autophagy-regulating TP53INP2 mediates muscle wasting and is repressed in diabetes.

Authors:  David Sala; Saška Ivanova; Natàlia Plana; Vicent Ribas; Jordi Duran; Daniel Bach; Saadet Turkseven; Martine Laville; Hubert Vidal; Monika Karczewska-Kupczewska; Irina Kowalska; Marek Straczkowski; Xavier Testar; Manuel Palacín; Marco Sandri; Antonio L Serrano; Antonio Zorzano
Journal:  J Clin Invest       Date:  2014-04-08       Impact factor: 14.808

9.  Identification of a novel modulator of thyroid hormone receptor-mediated action.

Authors:  Bernhard G Baumgartner; Meritxell Orpinell; Jordi Duran; Vicent Ribas; Hans E Burghardt; Daniel Bach; Ana Victoria Villar; José C Paz; Meritxell González; Marta Camps; Josep Oriola; Francisca Rivera; Manuel Palacín; Antonio Zorzano
Journal:  PLoS One       Date:  2007-11-21       Impact factor: 3.240

Review 10.  Onto better TRAILs for cancer treatment.

Authors:  D de Miguel; J Lemke; A Anel; H Walczak; L Martinez-Lostao
Journal:  Cell Death Differ       Date:  2016-03-04       Impact factor: 15.828
  10 in total
  3 in total

1.  Model-based analysis uncovers mutations altering autophagy selectivity in human cancer.

Authors:  Zhu Han; Weizhi Zhang; Wanshan Ning; Chenwei Wang; Wankun Deng; Zhidan Li; Zehua Shang; Xiaofei Shen; Xiaohui Liu; Otto Baba; Tsuyoshi Morita; Lu Chen; Yu Xue; Da Jia
Journal:  Nat Commun       Date:  2021-05-31       Impact factor: 14.919

2.  TP53INP1 exerts neuroprotection under ageing and Parkinson's disease-related stress condition.

Authors:  Emilie Dinh; Thomas Rival; Alice Carrier; Noemi Asfogo; Olga Corti; Christophe Melon; Pascal Salin; Sylviane Lortet; Lydia Kerkerian-Le Goff
Journal:  Cell Death Dis       Date:  2021-05-08       Impact factor: 8.469

3.  TP53INP2 Contributes to TGF-β2-Induced Autophagy during the Epithelial-Mesenchymal Transition in Posterior Capsular Opacification Development.

Authors:  Yilei Cui; Hao Yang; Silu Shi; Xiyuan Ping; Sifan Zheng; Xiajing Tang; Xiaoning Yu; Xingchao Shentu
Journal:  Cells       Date:  2022-08-02       Impact factor: 7.666
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.